Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives

por Heitmann, Jonas S., Pfluegler, Martin, Jung, Gundram, Salih, Helmut R.
Publicado 2021

Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia

por Märklin, Melanie, Hagelstein, Ilona, Koerner, Samuel P., Rothfelder, Kathrin, Pfluegler, Martin S., Schumacher, Andreas, Grosse-Hovest, Ludger, Jung, Gundram, Salih, Helmut R.
Publicado 2019

A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL

por Mehta, Naveen K, Pfluegler, Martin, Meetze, Kristan, Li, Bochong, Sindel, Isabelle, Vogt, Fabian, Marklin, Melanie, Heitmann, Jonas S, Kauer, Joseph, Osburg, Lukas, Zekri, Latifa, Bühring, Hans-Jörg, Mueller, Stefanie, Hörner, Sebastian, Baeuerle, Patrick A, Michaelson, Jennifer S, Jung, Gundram, Salih, Helmut R
Publicado 2022